Shattuck Labs, Inc.
NASDAQ: STTK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Taylor H. Schreiber
- Employees
- 44
- Headquarters
- Austin, United States
- IPO year
- 2020
- Market cap
- $287.9M
- Website
- https://www.shattucklabs.com
Loading STTK…
Loading profile data…Frequently asked questions about STTK
What does Shattuck Labs, Inc. (STTK) do?
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for...
Where does STTK trade?
Shattuck Labs, Inc. (STTK) trades on the NASDAQ Global Select.
What sector is STTK in?
Shattuck Labs, Inc. (STTK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shattuck Labs, Inc.?
Taylor H. Schreiber is the chief executive officer of Shattuck Labs, Inc. (STTK).
Where is Shattuck Labs, Inc. headquartered?
Shattuck Labs, Inc. is headquartered in United States.
Does STTK pay a dividend?
Shattuck Labs, Inc. (STTK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STTK go public?
Shattuck Labs, Inc. (STTK) completed its initial public offering in 2020.